Jane Street’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Jane Street's INMB Position: Q3 2026 in Review
Jane Street increased its INmune Bio (INMB) stake by 22% in Q3 2026, buying an estimated $60.9K and bringing the position to 163,858 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #9032.
Jane Street first reported a position in INMB in Q1 2021 and has held it in 11 quarters since. The position peaked at $869K in Q1 2024. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Jane Street held 163,858 shares of INmune Bio worth $320K as of Q3 2026.
- Jane Street bought 29,626 INmune Bio shares in Q3 2026, an estimated $60.9K.
- INmune Bio made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9032 holding.
- Jane Street first reported a position in INmune Bio in Q1 2021 and has held it in 11 quarters since.
- Jane Street's INmune Bio position peaked at $869K in Q1 2024.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.